SEC Form 5 · accession 0001479791-19-000002
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Dec 31, 2018
Accepted (ET)
Feb 1, 2019 · 6:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO BIOSCIENCE Common Stock | Feb 21, 2018 | S | 28,662 | $0.114 | D | 25,344,164 | D | |
| INVO BIOSCIENCE Common Stock | Feb 21, 2018 | S | 10,000 | $0.112 | D | 25,334,164 | D | |
| INVO BIOSCIENCE Common Stock | Feb 21, 2018 | S | 5,000 | $0.114 | D | 25,329,164 | D | |
| INVO BIOSCIENCE Common Stock | Feb 21, 2018 | S | 30,300 | $0.12 | D | 25,298,864 | D | |
| INVO BIOSCIENCE Common Stock | Feb 23, 2018 | S | 100 | $0.18 | D | 25,298,764 | D | |
| INVO BIOSCIENCE Common Stock | Feb 28, 2018 | S | 2,000 | $0.18 | D | 25,296,764 | D | |
| INVO BIOSCIENCE Common Stock | Feb 21, 2018 | S | 1,000 | $0.12 | D | 25,295,764 | D | |
| INVO BIOSCIENCE Common Stock | Mar 5, 2018 | S | 12,642 | $0.19 | D | 25,283,122 | D | |
| INVO BIOSCIENCE Common Stock | Oct 31, 2018 | A | 910,878 | $0.0001 | A | 26,194,000 | D | |
| INVO BIOSCIENCE Common Stock | Dec 3, 2018 | I | 1,000,000 | $0.0001 | D | 25,194,000 | D | |
| INVO BIOSCIENCE Common Stock | Dec 3, 2018 | S | 500,000 | $0.05 | D | 24,694,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Second Form-5 for year 2018 concerning the last 11 transactions that were not reported in the first Form-5